73097-02-6

Basic information

• Product Name: ethyl 2-chloro-4-nitrobenzoate
• Synonyms: ethyl 2-chloro-4-nitrobenzoate
• CAS NO: 73097-02-6
• Molecular Weight: 229.62
• Mol File: 73097-02-6.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: ethyl 2-chloro-4-nitrobenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 2-chloro-4-nitrobenzoate(73097-02-6)
• EPA Substance Registry System: ethyl 2-chloro-4-nitrobenzoate(73097-02-6)

Safety Data

• Hazardous Substances Data: 73097-02-6(Hazardous Substances Data)

Upstream product

• 64-17-5 ethanol 
• 99-60-5 2-chloro-4-nitrobenzoic acid 
• 77455-54-0 2-chloro-4-nitrobenzal diacetate 
• 5568-33-2 2-chloro-4-nitrobenzaldehyde 
• 121-86-8 2-chloro-4-nitrotoluene 
• 77455-65-3 3-chloro-4-(dichloromethyl)-1-nitrobenzene 

Downstream Products

• 10367-96-1 2-(diethylamino)ethyl 2-chloro-4-nitrobenzoate 
• 89-40-7 4-nitrophthalimide 
• 1057076-51-3 ethyl 4-amino-2-chloro-5-iodobenzoate 
• 67345-78-2 2-chloro-4-nitrobenzohydrazide 
• 915390-03-3 ethyl 2-(morpholin-4-yl)-4-nitrobenzoate 
• 1346123-90-7 [4-amino-2-(morpholin-4-yl)phenyl][4-(2,4-dimethylphenyl)piperazin-1-yl]methanone 
• 1346123-91-8 [4-(2,4-dimethylphenyl)piperazin-1-yl][2-(morpholin-4-yl)-4-nitrophenyl]methanone 
• 94-09-7 p-aminoethylbenzoate 
• 119342-76-6 2,2'-dichloro-4,4'-azoxy-di-benzoic acid diethyl ester 
• 16017-69-9 ethyl-2-chloro-4-amino-benzoate 

Relevant articles and documents

RETINOID COMPOUND AND PHARMACEUTICAL COMPOSITION

PROBLEM TO BE SOLVED: To provide a novel retinoid compound that is low in teratogenicity, and a pharmaceutical composition containing said retinoid compound. SOLUTION: Provided are a retinoid compound which is a compound represented by the following formula (1) or a salt thereof, and a pharmaceutical composition containing said retinoid compound. In the formula, R1 represents a halogen atom, and R2 and R3 each independently represent a silyl group. SELECTED DRAWING: None COPYRIGHT: (C)2020,JPOandINPIT

Discovery of pyrido[3,4-g]quinazoline derivatives as CMGC family protein kinase inhibitors: Design, synthesis, inhibitory potency and X-ray co-crystal structure

The design and synthesis of new pyrido[3,4-g]quinazoline derivatives is described as well as their protein kinase inhibitory potencies toward five CMGC family members (CDK5, CK1, GSK3, CLK1 and DYRK1A). The interest for this original tricyclic heteroaroma

Guanidino substituted isoindolones as novel glycoprotein IIb-IIIa receptor antagonists

Design and synthesis of a novel potent glycoprotein IIb-IIIa (GP IIb-IIIa) receptor antagonist based on isoindolone skeleton has been described. This scaffold has been derived from earlier reported pseudopeptides. Synthesis by a novel route has been achieved. Few molecules show very potent in vitro activity. Further identification of probable additional hydrogen bond donor site has been described.